Mesenchymal stem cell therapy for heart failure: a meta-analysis.
CONCLUSION: Although MSC treatment can significantly improve LVEF and reduce rehospitalization rates, it does not have a significant influence on cardiovascular death, myocardial infarction, heart failure, and total death.
PMID: 30341444 [PubMed - as supplied by publisher]
Source: Herz - Category: Cardiology Tags: Herz Source Type: research
More News: Cardiology | Cardiovascular | Heart | Heart Attack | Heart Failure | Stem Cell Therapy | Stem Cells | Study